Physician profile
Patrick Thomas Mccarthy
NPI 1114480902
$537.14
in general payments reported to CMS, 2019-2025
12 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $257 · 2024: $177 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $537.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $537.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $257.17 | 2023 | Arista Ah Flexitip |
| Pfizer INC. | $75.66 | 2024-2025 | |
| Organon LLC | $38.49 | 2024-2025 | Nexplanon |
| Biogen, INC. | $22.32 | 2025 | Zurzuvae |
| Evofem Biosciences, INC. | $21.47 | 2024 | |
| Exeltis, USA INC. | $19.97 | 2024 | Slynd |
| Exact Sciences Corporation | $19.61 | 2025 | Cologuard Collection Kit |
| Optumhealth Care Solutions, LLC | $19.24 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Baxter Healthcare | $16.80 | 2024 | Perclot |
| Lsi Solutions INC | $15.82 | 2024 | Fornisee |
| Bayer Healthcare Pharmaceuticals INC. | $15.69 | 2024 | |
| Novo Nordisk INC | $14.90 | 2024 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Mccarthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.